Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein

Due to early onset of local invasion and distant metastasis, pancreatic cancer is the most lethal human malignant tumor, with a 5 year survival rate of less than 5%. As a effective chemotherapy drug for pancreatic cancer patients, gemcitabine is reported to inhibit cell proliferation as a nucleotide...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiansheng, Huang, Mei, Xie, Fang, Zhou, Hangcheng, Yang, Ji, Huang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342537/
https://www.ncbi.nlm.nih.gov/pubmed/27602753
http://dx.doi.org/10.18632/oncotarget.11780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342537/
https://www.ncbi.nlm.nih.gov/pubmed/27602753
http://dx.doi.org/10.18632/oncotarget.11780

Ejemplares similares